Branded Generics Market Size, Share, Outlook, and Opportunity Analysis, 2020– 2027

BRANDED GENERICS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027

© Coherent market Insights. All Rights Reserved

REPORT DESCRIPTION Branded Generics Market - Overview Branded generics require low research or development costs compared to the branded prescription products. Companies that operate in branded generic business invest majorly in marketing the product and to create brand awareness.

The global Branded Generics Market is estimated to account for US$ 247.0 Mn in terms of value in 2019 and is expected to reach US$ 444.0 Mn by the end of 2027.

Global Branded Generics Market: Drivers Increasing affordability and guidelines of products to boost growth of the branded generics market over the forecast period. The company with New Drug Application (NDA) must notify the FDA in order to market an authorized generic. The company with the NDA is allowed to market both the authorized generic and the brand drug simultaneously.

Global Branded Generics Market: Opportunities Players in the market can focus on expanding their business in emerging markets. This is owing to increasing demand for generic drugs in these markets. For instance, according to India Brand Equity Foundation, the pharmaceutical sector in India supplies over 50% of global demand for various vaccines, 40% of generic demand in the U.S. and 25% of all medicine in U.K. Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/brandedgenerics-market-3391 Š Coherent market Insights. All Rights Reserved

REPORT DESCRIPTION Global Branded Generics Market: Restraints Misuse of Risk Evaluation and Mitigation Strategies (REMS) to delay generic market entry is also expected to hinder growth of the market. Branded drug manufacturers/drug discovery companies use REMS to withhold access to drug samples for generic manufacturers’ bioequivalence testing and development. This in turn delays entry of branded generic drugs in the market.

Key Takeaways: Oral segment in the global branded generics market was valued at US$ 134.8 Mn in 2018 and is expected to reach US$ 258.9 Mn by 2027 at a CAGR of 7.3% during the forecast period.

Oral medications is easy to administer and patient compliance with oral medication is higher than other routes of administration, mainly, due to ease of administration.

Moreover, tablets, and capsules can be made more palatable using sweeteners, and colored coating. These factors are expected to support growth of the segment.

The retail pharmacies segment held dominant position in the global branded generics market in 2018, accounting for 45.4% share in terms of value, followed by hospital pharmacies and drug stores, respectively.

Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/3391 Š Coherent market Insights. All Rights Reserved

REPORT DESCRIPTION Market Trends Some states in the U.S. are focused on launching state-produced branded generics to reduce healthcare cost. For instance, in January 2020, the state government of California announced its plans to introduce its own brand of generic prescription drugs in order to reduce healthcare costs.

Major players in the market are offering discounts on their branded generics. For instance, in January 2020, Eli Lilly and Company announced its plans to offer half-price generic versions of its fast-acting Humalog Junior KwikPen insulin and Humalog Mix75/25 KwikPen.

Regulations Pharmaceutical products in Europe are regulated by European Commission in consultation with the competent authorities of the Member States and the European Medicines Agency (EMEA) The manufacturer or distributor of generic or multisource drugs in Europe must obtain Marketing Authorization Application (MAA) trough one of three procedures as indicated below

Global Branded Generics Market: Competitive Landscape Major players operating in the global branded generics market include, Mylan N.V, Novartis AG, Teva Pharmaceutical Industries Ltd., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Aspen Pharmacare Holding Ltd., Abbott Laboratories, and Valeant Pharmaceuticals International, Inc.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3391 Š Coherent market Insights. All Rights Reserved

ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.

SERVICES INDUSTRY ANALYSIS

CUSTOMIZED RESEARCH

SYNDICATED RESEARCH

MARKET INTELLIGENCE SERVICES

CONSULT STUDIES

COUNTRY SPECIFIC STUDIES

Š Coherent market Insights. All Rights Reserved

ABOUT CMI SECTOR COVERAGE

BIOTECHNOLOGY

CLINICAL DIAGNOSTIC

HEALTHCARE IT

MEDICAL DEVICES

MEDICAL IMAGING

PHARMACEUTICAL

OUR CLIENTS

 Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators

 Private and Government organization

 Distributors, Retailors and Value Added Resellers

 Outsourcing Companies

 Healthcare IT Solutions Developers

 Universities and Business Schools.

© Coherent market Insights. All Rights Reserved

KEY STATS

RESEARCH SOLUTIONS

100+

FEASIBILITY STUDIES

Insights Published Per Year

GLOBAL REPORTS

150+

Consulting Projects Till Date

COUNTRY ANALYSIS CONSULT PROJECTS

125+

Clients Worldwide Per Year

110+

SURVEY RESEARCH

EXCEL FORECAST DATABASE

CUSTOMIZED SOLUTIONS

COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS

Analysts and Contract Consultants

Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702

Š Coherent market Insights. All Rights Reserved